 |
|
Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients
Woo Jin Chung
Clin Mol Hepatol. 2012;18(3):268-271. Published online 2012 Sep 25 DOI: https://doi.org/10.3350/cmh.2012.18.3.268
|
|
Citations to this article as recorded by
 Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting syste
Maurizio Sessa, Francesca Futura Bernardi, Andrea Vitale, Beniamino Schiavone, Giulia Gritti, Annamaria Mascolo, Michele Bertini, Cristina Scavone, Liberata Sportiello, Francesco Rossi, Annalisa Capuano
Journal of Clinical Pharmacy and Therapeutics.2018; 43(6): 867. CrossRef
|